MCID: ADL027
MIFTS: 37

Adult Dermatomyositis

Categories: Muscle diseases, Skin diseases, Rare diseases, Neuronal diseases, Nephrological diseases, Bone diseases

Aliases & Classifications for Adult Dermatomyositis

MalaCards integrated aliases for Adult Dermatomyositis:

Name: Adult Dermatomyositis 12 14
Adult Onset Dermatomyositis 12
Adult Type Dermatomyositis 69

Classifications:



External Ids:

Disease Ontology 12 DOID:14202

Summaries for Adult Dermatomyositis

MalaCards based summary : Adult Dermatomyositis, also known as adult onset dermatomyositis, is related to calcinosis and dermatomyositis. An important gene associated with Adult Dermatomyositis is MBL2 (Mannose Binding Lectin 2), and among its related pathways/superpathways are Toll-like Receptor Signaling Pathway and Tuberculosis. The drugs Abatacept and Pirfenidone have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and lung.

Related Diseases for Adult Dermatomyositis

Diseases in the Dermatomyositis family:

Adult Dermatomyositis

Diseases related to Adult Dermatomyositis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 104)
id Related Disease Score Top Affiliating Genes
1 calcinosis 29.7 TLR9 TNF
2 dermatomyositis 11.5
3 childhood type dermatomyositis 10.9
4 walker dyson syndrome 10.6 MBL2 TNF
5 phlyctenulosis 10.6 MBL2 TNF
6 functional gastric disease 10.6 MBL2 TNF
7 endogenous depression 10.5 MBL2 TNF
8 pericardium disease 10.5 MBL2 TNF
9 rete ovarii adenoma 10.5 CHKB TNF
10 ampulla of vater neoplasm 10.5 CHKB TNF
11 urethra transitional cell carcinoma 10.5 TNF VDR
12 pityriasis rosea 10.4 TNF VDR
13 vacterl association 10.4 TNF VDR
14 charcot-marie-tooth disease 10.4 MBL2 TNF
15 premature ovarian failure 12 10.4 MBL2 TNF
16 hepadnavirus infection 10.3 GPT TNF
17 megaloblastic anemia 10.3 GPT TNF
18 cutaneous fibrous histiocytoma 10.3 GPT TNF
19 bladder sarcoma 10.3 GPT TNF
20 hemolytic-uremic syndrome 10.3 GPT TNF
21 paranasal sinus sarcoma 10.3 GPT TNF
22 alopecia 10.3 GPT TNF
23 congenital hypoplastic anemia 10.2 GPT TNF
24 bubonic plague 10.2 GPT TNF
25 isthmus cancer 10.2 GPT TNF
26 central nervous system leiomyosarcoma 10.2 TLR9 TNF
27 tularemia 10.2 TLR9 TNF
28 acute vascular insufficiency of intestine 10.1 TLR9 TNF
29 brucella canis brucellosis 10.1 TLR9 TNF
30 isolated growth hormone deficiency 10.1 GPT VDR
31 testicular infarct 10.1 TLR9 TNF
32 myeloid sarcoma 10.1 TLR9 TNF
33 ostertagiasis 10.1 TLR9 TNF
34 membranoproliferative glomerulonephritis 10.1 TLR9 TNF
35 early congenital syphilis 10.1 TLR9 TNF
36 mucositis 10.1 MBL2 TLR9
37 mikulicz disease 10.1 TLR9 TNF
38 motor peripheral neuropathy 10.1 TLR9 TNF
39 breast disease 10.1 TLR9 TNF
40 dehydration polycythemia 10.1 TLR9 TNF
41 sublingual gland cancer 10.1 TLR9 TNF
42 dieulafoy lesion 10.1 MBL2 TLR9
43 pelvic varices 10.1 TLR9 TNF
44 benign mammary dysplasia 10.1 TLR9 TNF
45 legionellosis 10.1 TLR9 TNF
46 heart sarcoma 10.1 TLR9 TNF
47 tinea barbae 10.1 MBL2 TLR9
48 spondylolysis 10.1 TLR9 TNF
49 gastric ulcer 10.1 TLR9 TNF
50 acute interstitial pneumonia 10.1 TLR9 TNF

Graphical network of the top 20 diseases related to Adult Dermatomyositis:



Diseases related to Adult Dermatomyositis

Symptoms & Phenotypes for Adult Dermatomyositis

Drugs & Therapeutics for Adult Dermatomyositis

Drugs for Adult Dermatomyositis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 114)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Abatacept Approved Phase 4,Phase 3,Phase 2 332348-12-6 10237
2
Pirfenidone Investigational Phase 4 53179-13-8 40632
3 Vaccines Phase 4
4 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
5 Hormones Phase 4,Phase 3,Phase 2,Phase 1
6 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
11 Adrenocorticotropic Hormone Phase 4,Phase 2
12 beta-endorphin Phase 4,Phase 2
13 Melanocyte-Stimulating Hormones Phase 4,Phase 2
14 Analgesics Phase 4,Phase 2,Phase 3,Phase 1
15 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1
16 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 3,Phase 1
17
Levoleucovorin Approved Phase 3,Phase 2 68538-85-2
18
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
19
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2 83-43-2 6741
20
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
21
Prednisolone Approved, Vet_approved Phase 3,Phase 2 50-24-8 5755
22
Prednisone Approved, Vet_approved Phase 3,Phase 2 53-03-2 5865
23
Benzocaine Approved Phase 2, Phase 3 1994-09-7, 94-09-7 2337
24
Tacrolimus Approved, Investigational Phase 2, Phase 3 104987-11-3 445643 439492
25
Alendronate Approved Phase 2, Phase 3 121268-17-5, 66376-36-1 2088
26
Infliximab Approved Phase 2, Phase 3 170277-31-3
27
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Phase 1 50-18-0, 6055-19-2 2907
28
rituximab Approved Phase 2, Phase 3 174722-31-7 10201696
29
Etanercept Approved, Investigational Phase 2, Phase 3,Phase 1 185243-69-0
30
belimumab Approved Phase 2, Phase 3 356547-88-1 5957 10451420
31
Acetylcysteine Approved, Investigational Phase 2, Phase 3 616-91-1 12035
32
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
33
leucovorin Approved, Nutraceutical Phase 3,Phase 2 58-05-9 143 6006
34 tannic acid Approved, Nutraceutical Phase 2, Phase 3
35 Antiemetics Phase 3,Phase 2
36 Antifungal Agents Phase 3,Phase 2
37 Anti-Infective Agents Phase 3,Phase 2,Phase 1
38 Antimetabolites Phase 3,Phase 2
39 Antimetabolites, Antineoplastic Phase 3,Phase 2
40 Antineoplastic Agents, Hormonal Phase 3,Phase 2
41 Autonomic Agents Phase 3,Phase 2
42 Calcineurin Inhibitors Phase 3,Phase 2
43 Cyclosporins Phase 3,Phase 2
44 Dermatologic Agents Phase 3,Phase 2
45 Folic Acid Antagonists Phase 3,Phase 2
46 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
47 glucocorticoids Phase 3,Phase 2,Phase 1
48 Methylprednisolone acetate Phase 3,Phase 2
49 Methylprednisolone Hemisuccinate Phase 3,Phase 2
50 Neuroprotective Agents Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 80)

id Name Status NCT ID Phase Drugs
1 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Unknown status NCT00815282 Phase 4 Human papilloma virus vaccine (cervarix)
2 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
3 Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis Recruiting NCT02245841 Phase 4 H.P. Acthar Gel
4 Abatacept in Juvenile Dermatomyositis Recruiting NCT02594735 Phase 4 Abatacept
5 MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study Active, not recruiting NCT03226119 Phase 4
6 Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis Not yet recruiting NCT02821689 Phase 4 Pirfenidone
7 Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis Unknown status NCT00323960 Phase 3 3 MPDN pulse + PDN;3 MPDN pulse + PDN + CSA;3 MPDN pulse + PDN + MTX
8 Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus Unknown status NCT00504348 Phase 2, Phase 3 Tacrolimus
9 Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) Completed NCT00335985 Phase 3 GB-0998;Placebo of GB-0998
10 Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM Completed NCT00651040 Phase 3 Prednisone;Methotrexate
11 Alendronate Osteoporosis Study Completed NCT00277251 Phase 2, Phase 3 Alendronate
12 Anakinra in Myositis Completed NCT01165008 Phase 2, Phase 3 Anakinra
13 Treatment With TNF Blockade, Infliximab, in Patients With Myositis Completed NCT00443222 Phase 2, Phase 3 Infliximab
14 Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) Recruiting NCT02728752 Phase 3 Octagam 10%
15 Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD Recruiting NCT01862926 Phase 2, Phase 3 Rituximab;Cyclophosphamide
16 Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy Recruiting NCT02971683 Phase 3 Abatacept subcutaneous;Placebo
17 Belimumab in Myositis Recruiting NCT02347891 Phase 2, Phase 3 Belimumab;Placebo
18 Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis Terminated NCT00035958 Phase 2, Phase 3 Prednisone;Methotrexate;Etanercept
19 A Clinical Trial for CTD-ILD Treatment Terminated NCT01424033 Phase 2, Phase 3 N-Acetylcysteine
20 Abatacept Treatment in Polymyositis and Dermatomyositis Unknown status NCT01315938 Phase 2 Abatacept;Abatacept
21 Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis Completed NCT01572844 Phase 2 Sodium thiosulfate
22 Acthar in Treatment of Refractory Dermatomyositis and Polymyositis Completed NCT01906372 Phase 2 Adrenocorticotropic Hormone Gel
23 Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis Completed NCT00005571 Phase 2 h5G1.1-mAb
24 Safety and Efficacy of BAF312 in Dermatomyositis Completed NCT02029274 Phase 2 BAF312 0.5 mg;BAF312 2 mg;BAF312 10 mg;Placebo to BAF312
25 Methimazole to Treat Polymyositis and Dermatomyositis Completed NCT00001421 Phase 2 methimazole
26 Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis Completed NCT00033891 Phase 2 Infliximab
27 Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis Completed NCT01415219 Phase 2
28 Absorption of Corticosteroids in Children With Juvenile Dermatomyositis Completed NCT00004357 Phase 2 Methylprednisolone;Prednisolone
29 Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Completed NCT00106184 Phase 2 Rituximab;Placebo
30 Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies Completed NCT00001261 Phase 2 Gamma Globulin
31 A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis Completed NCT00979654 Phase 2 Sifalimumab
32 Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis Recruiting NCT03267277 Phase 2 Sodium Thiosulfate
33 Study of IFN-K in Dermatomyositis Recruiting NCT02980198 Phase 2
34 Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis Recruiting NCT02043548 Phase 2 tocilizumab;placebo
35 Trial of IMO-8400 in Adult Patients With Dermatomyositis Active, not recruiting NCT02612857 Phase 2 IMO-8400 Dose Group 1;IMO-8400 Dose Group 2;Placebo
36 Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis Active, not recruiting NCT02466243 Phase 2 JBT-101;Placebo;JBT-101 Open-label
37 A Study In Adults With Moderate To Severe Dermatomyositis Not yet recruiting NCT03181893 Phase 2 PF-06823859;Placebo Arm
38 Basiliximab Treating Interstitial Pneumonia of CADM Not yet recruiting NCT03192657 Phase 2 Basiliximab;Calcineurin Inhibitors;Steroids
39 Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders Not yet recruiting NCT02418273 Phase 1, Phase 2 denosumab
40 Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis Terminated NCT01148810 Phase 2 BAF312;Placebo
41 A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis Withdrawn NCT01918904 Phase 2 Sodium thiosulfate;Placebo
42 Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD Withdrawn NCT01025739 Phase 2
43 A Pilot Study of Etanercept in Dermatomyositis Completed NCT00112385 Phase 1 Etanercept;Placebo
44 A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis Completed NCT00533091 Phase 1
45 Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Completed NCT00010335 Phase 1
46 Mycophenolate Mofetil in Systemic Sclerosis Completed NCT00433186 Phase 1 Mycophenolate Mofetil
47 Study of Tofacitinib in Refractory Dermatomyositis Recruiting NCT03002649 Phase 1 Tofacitinib
48 A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases Active, not recruiting NCT02780674 Phase 1
49 Creatine Supplementation in Pediatric Rheumatology Unknown status NCT01217320
50 The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis Unknown status NCT02267005

Search NIH Clinical Center for Adult Dermatomyositis

Genetic Tests for Adult Dermatomyositis

Anatomical Context for Adult Dermatomyositis

MalaCards organs/tissues related to Adult Dermatomyositis:

39
Bone, Skin, Lung, Heart, Eye, Colon

Publications for Adult Dermatomyositis

Articles related to Adult Dermatomyositis:

(show top 50) (show all 79)
id Title Authors Year
1
Liposteroid therapy for juvenile and adult dermatomyositis: efficacy and side effects. ( 28361075 )
2017
2
Environmental factors associated with disease flare in juvenile and adult dermatomyositis. ( 28444299 )
2017
3
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ( 28385805 )
2017
4
The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients. ( 28129490 )
2017
5
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis. ( 27803134 )
2017
6
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ( 28382787 )
2017
7
Extensive calcinosis in adult dermatomyositis. ( 28396153 )
2017
8
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. ( 27121733 )
2016
9
Adult dermatomyositis associated with benign ovarian teratoma: A case report. ( 27073526 )
2016
10
Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome". ( 27660942 )
2016
11
Association of vitamin D receptor gene BsmI B/b and FokI F/f polymorphisms with adult dermatomyositis and systemic lupus erythematosus. ( 26972080 )
2016
12
Colonic vasculopathy and perforation in the initial presentation of adult dermatomyositis in a patient with improving muscle weakness. ( 26759443 )
2016
13
Anti-TIF1-I^-positive young adult dermatomyositis with germ cell tumour. ( 27457276 )
2016
14
Clinico pathological study of adult dermatomyositis: Importance of muscle histology in the diagnosis. ( 26019418 )
2015
15
Severe adult dermatomyositis with unusual calcinosis. ( 26286744 )
2015
16
Gastrointestinal endarteropathy in adult dermatomyositis. ( 26184526 )
2015
17
HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population. ( 24894810 )
2014
18
IL-1RN VNTR Polymorphism in Adult Dermatomyositis and Systemic Lupus Erythematosus. ( 25328514 )
2014
19
A case of adult dermatomyositis with calcinosis universalis. ( 25400376 )
2014
20
Adult dermatomyositis with bleeding ulcer in the pharynx. ( 25328739 )
2014
21
Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. ( 23139205 )
2013
22
Focal lipodystrophy without metabolic disorders in adult dermatomyositis. ( 22804743 )
2013
23
MBL2 polymorphisms - manifestations in bulgarian patients with adult dermatomyositis and systemic lupus erythematosus. ( 24103065 )
2013
24
Lacy reticular-pattern calcinosis in adult dermatomyositis. ( 23908532 )
2013
25
A case of adult dermatomyositis associated with parainfluenza virus infection and Jo-1 antibody. ( 24341326 )
2013
26
Renal cell carcinoma-associated adult dermatomyositis treated laparoscopic nephrectomy. ( 24311917 )
2013
27
Adult dermatomyositis associated with lipodystrophy. ( 23962582 )
2013
28
Therapy of calcinosis universalis complicating adult dermatomyositis. ( 24131911 )
2013
29
Adult dermatomyositis: experience of a Brazilian tertiary care center. ( 23223700 )
2012
30
Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. ( 22886447 )
2012
31
Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. ( 21710176 )
2012
32
Association of TNF-I+ polymorphisms with adult dermatomyositis and systemic lupus erythematosus in Bulgarian patients. ( 22913362 )
2012
33
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. ( 21947177 )
2011
34
Adult dermatomyositis with severe polyneuropathy: does neuromyositis exist? ( 20229079 )
2010
35
An extremely severe case of cutaneous calcinosis complicating adult dermatomyositis. ( 19076816 )
2009
36
Clinical characteristics and outcomes of juvenile and adult dermatomyositis. ( 19654958 )
2009
37
Case of pneumatosis cystoides intestinalis in adult dermatomyositis. ( 18181780 )
2008
38
Calcinosis cutis: a rare feature of adult dermatomyositis. ( 18319027 )
2008
39
Tracheoesophageal fistula: a rare complication of adult dermatomyositis. ( 18474474 )
2008
40
Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis. ( 17938031 )
2007
41
Acute-onset adult dermatomyositis presenting with erythroderma and diplopia. ( 17868397 )
2007
42
Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. ( 16431335 )
2006
43
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association. ( 17170621 )
2006
44
Regression of cutis calcinosis with diltiazem in adult dermatomyositis. ( 15757822 )
2005
45
Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis. ( 15789887 )
2005
46
Clinical significance of von Willebrand factor in patients with adult dermatomyositis. ( 15565394 )
2005
47
Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with infliximab. ( 15317960 )
2004
48
Pruritus in adult dermatomyositis. ( 15115510 )
2004
49
Digital infarcts showing microangiopathy in adult dermatomyositis suggest severe pulmonary involvement and poor prognosis. ( 15214917 )
2004
50
Uncertainties in the pathogenesis of adult dermatomyositis. ( 15167072 )
2004

Variations for Adult Dermatomyositis

Expression for Adult Dermatomyositis

Search GEO for disease gene expression data for Adult Dermatomyositis.

Pathways for Adult Dermatomyositis

GO Terms for Adult Dermatomyositis

Biological processes related to Adult Dermatomyositis according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.65 TLR9 TNF VDR
2 positive regulation of JNK cascade GO:0046330 9.49 TLR9 TNF
3 positive regulation of interleukin-6 production GO:0032755 9.46 TLR9 TNF
4 positive regulation of JUN kinase activity GO:0043507 9.43 TLR9 TNF
5 defense response to bacterium GO:0042742 9.43 MBL2 TLR9 TNF
6 positive regulation of phagocytosis GO:0050766 9.4 MBL2 TNF
7 positive regulation of interleukin-8 production GO:0032757 9.37 TLR9 TNF
8 negative regulation of interleukin-6 production GO:0032715 9.32 TLR9 TNF
9 positive regulation of NF-kappaB import into nucleus GO:0042346 9.16 TLR9 TNF
10 positive regulation of chemokine production GO:0032722 8.96 TLR9 TNF
11 negative regulation of growth of symbiont in host GO:0044130 8.62 MBL2 TNF

Sources for Adult Dermatomyositis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....